FingerPaint Acquires Engage To Improve Omnichannel Offerings

What to Read Next

1. How to Reinvent Growth Strategies to Match Customer Needs?

2. Webidoo Brings AI-Powered Marketing Tools to MEA

3. Hyland Debuts Hyland Experience Automate

4. Veritonic Integrates AppsFlyer

The acquisition will bolster Fingerpaint’s omnichannel offering, data and analytics capabilities, and global presence.

Fingerpaint, biopharma’s global commercialisation partner for analytics-enabled integrated solutions, announced that it has acquired Engage, a London-based, data and analytics–enabled healthcare marketing firm.  Details of the transaction were not disclosed.

Engage will expand Fingerpaint’s European footprint and complement the company’s current data and analytics expertise.

“Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide,” said Ed Mitzen, founder of Fingerpaint. “Our combined global omnichannel marketing solutions guided by—and rooted in—data will further Fingerpaint’s position as a transformative digital partner to biopharma’s commercialisation needs.”

Also Read: Do you YouTube?

Mary McGregor and Dave Chandler, both founders and managing partners of Engage, will continue to lead day-to-day operations.

“Integrating into Fingerpaint will allow us to leverage its award-winning creative and digital talent and maximise omnichannel campaigns as we continue to work with global brands at every stage of the commercialisation process,” said McGregor.

“Combining our expertise with Fingerpaint’s will create best-in-class, performance-based digital capabilities for clients across the company’s integrated firms,” said Chandler.

Knox Lane, a private equity firm based in San Francisco, is a strategic investor in Fingerpaint. “Engage will help expand the data and analytics capabilities the industry has come to expect from Fingerpaint, biopharma’s leading commercialisation partner,” said Shamik Patel, partner at Knox Lane.